Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · March 16, 2023

Efficacy and Safety of Antithrombotic Strategies Within and Beyond 12 Months in Patients With Established CAD

European Heart Journal: Cardiovascular Pharmacotherapy


Additional Info

Disclosure statements are available on the authors' profiles:

European Heart Journal: Cardiovascular Pharmacotherapy
Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease. Two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC) and European Association of Preventive Cardiology (EAPC)
Eur Heart J Cardiovasc Pharmacother 2023 Mar 03;[EPub Ahead of Print], EP Navarese, A Landi, A Oliva, R Piccolo, V Aboyans, D Angiolillo, D Atar, D Capodanno, KAA Fox, S Halvorsen, S James, P Jüni, V Kunadian, S Leonardi, R Mehran, G Montalescot, J Niebauer, S Price, RF Storey, H Völler, P Vranckx, S Windecker, M Valgimigli

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading